Aptar Pharma Co-Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril, Portugal
March 21, 2019
Pharma
Aptar Pharma to Showcase New Market Innovations at Interphex 2019, New York City
March 21, 2019
Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression
March 18, 2019
Aptar Pharma to Exhibit Latest Injectable Developments at 2019 PDA Annual Meeting, San Diego, CA
March 6, 2019
Aptar Pharma’s Preservative-Free Multidose Dispenser Approved Across Europe for Santen’s Taflotan®/Saflutan® Prescription Treatment
February 26, 2019
Aptar Pharma QuickStart™ Injectables, a Drug Development Solution Available Online, Wins Industry Innovation Award at Pharmapack 2019
February 7, 2019
Pulmonary and Nasal Drug Delivery Experts to Attend RDD Europe 2019, May 7-10, Estoril, Portugal
January 8, 2019
Aptar Pharma to Exhibit Latest Innovations at Pharmapack 2019, Paris
December 20, 2018
Aptar Pharma to Highlight its Latest Innovations at CPhI India 2018, Delhi NCR, India
December 6, 2018
Aptar Pharma to Showcase Latest Connected Health Innovations and New Active Packaging Technologies at DDL 2018
November 28, 2018
Aptar Pharma Co-Organizes the Third Edition of RDD Asia® in Kerala, India
November 5, 2018
Aptar Pharma QuickStart™, an injectable device development kit, to launch at CPhI Worldwide
October 9, 2018
Aptar Pharma Launches PureHale, a New Portable and Ready-to-Use Upper Respiratory Delivery Solution
Join Aptar Pharma’s Live Webinar “Good Medicine: Solutions for Sensitive Injectable Formulations”
October 1, 2018
Aptar Pharma to Showcase Our Latest Offerings at PDA PFS, Orlando, Florida October 8-9, 2018
September 25, 2018
Aptar Pharma to launch PureHale and showcase its portfolio of connected devices at CPhI Worldwide
September 17, 2018
Join Aptar Pharma’s Live Webinar “Decoding the FDA’s Recent Combination Drug Product Guidance: Applications to DPIs, pMDIs, and Nasal Sprays”
August 27, 2018
Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM
Aptar Pharma and Propeller Health Discuss the Four Keys to Success for Connected Medicines in ONdrugDelivery’s June Issue
June 20, 2018
